GSK vets Wit­ty and Slaoui find new roles in biotech as the great mi­gra­tion con­tin­ues

An­drew Wit­ty has signed on as a part­ner at Durham, NC-based Hat­teras. “An­drew Wit­ty we be­lieve brings the high­est lev­el of un­der­stand­ing about the phar­ma in­dus­try as a whole,” Hat­teras gen­er­al part­ner Bob In­gram tells End­points News, count­ing off Wit­ty’s lead­ing roles in the glob­al com­mer­cial as well as R&D side of the busi­ness. In­gram says Wit­ty — like­ly the on­ly knight­ed mem­ber of the biotech ven­ture com­mu­ni­ty — is ex­pect­ed to help ad­vise the firm and its biotech com­pa­nies, lend­ing some of his ster­ling Big Phar­ma rep to the or­ga­ni­za­tion as it grows up new com­pa­nies. And, you can add one more new biotech role for ex-GSK CEO. The for­mer phar­ma chief has joined the ad­vi­so­ry board at Syn­thego, a genome en­gi­neer­ing out­fit based in Red­wood City, CA.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.